Adjuvant and neoadjuvant therapies of pancreatic cancer Jules HarrisHoward Bruckner Review Pages: 1 - 7
Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer C. H. CraneN. A. JanjanJ. L. Abbruzzese OriginalPaper Pages: 9 - 18
WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment Thinh P. PhanChristopher H. CraneKathy A. Mason OriginalPaper Pages: 19 - 23
Mouse models of metastatic pancreatic adenocarcinoma Keping XieBailiang WangXiangdong Le OriginalPaper Pages: 25 - 35
A novel, clinically relevant animal model of metastatic pancreatic adenocarcinoma biology and therapy Bailiang WangQian ShiKeping Xie OriginalPaper Pages: 37 - 46
Expression of heparin-binding epidermal growth factor-like growth factor in pancreatic adenocarcinoma Yasuhiro ItoShigeki HigashiyamaNariaki Matsuura OriginalPaper Pages: 47 - 52
Adenosquamous carcinoma of the pancreas Hiroki YamaueHiroshi TanimuraKazuhisa Uchiyama OriginalPaper Pages: 53 - 58
Emergency pancreaticoduodenectomy with delayed reconstruction for bleeding Jean-Jacques TuechPatrick PessauxJean-Pierre Arnaud OriginalPaper Pages: 59 - 62
Resectable pleomorphic giant cell carcinoma of the pancreas Takatsugu YamamotoKazuhiro HirohashiHiroaki Kinoshita Case Report Pages: 63 - 67